Tenaya Therapeutics is trading at $0.80 (-8.05%) in pre-market, reflecting normal volatility for a speculative biotech stock following a volatile run in early July.
- No fresh company-specific announcements or analyst actions have been reported to justify the price action.
- Broader risk sentiment is softer, with Nasdaq futures and the Nasdaq Composite both trading lower.